Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038362 (
stomatitis
)
8,852
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Intron retention (IR) has emerged as an important mechanism of gene expression control, but the factors controlling IR events remain poorly understood. We observed consistent IR in one intron of the Irf7 gene and identified
BUD13
as an RNA-binding protein that acts at this intron to increase the amount of successful splicing. Deficiency in
BUD13
was associated with increased IR, decreased mature Irf7 transcript and protein levels, and consequently a dampened type I interferon response, which compromised the ability of
BUD13
-deficient macrophages to withstand vesicular
stomatitis
virus (VSV) infection. Global analysis of
BUD13
knockdown and
BUD13
cross-linking to RNA revealed a subset of introns that share many characteristics with the one found in Irf7 and are spliced in a
BUD13
-dependent manner. Deficiency of
BUD13
led to decreased mature transcript from genes containing such introns. Thus, by acting as an antagonist to IR,
BUD13
facilitates the expression of genes at which IR occurs.
...
PMID:BUD13 Promotes a Type I Interferon Response by Countering Intron Retention in Irf7. 3063 43